Phlexglobal to Host Trial Master File World Forum in the United States and United Kingdom

Leading Authority in TMF Technology and Services for pharmaceutical companies to host two complimentary events on Reaching the TMF Health Zone

shutterstock_679945117

Amersham, UK; Malvern, PA. — September 9, 2019 — This Autumn Phlexglobal will host the annual TMF World Forum, two exciting events focused on helping the life science industry, including pharmaceutical companies, clinical research organizations, and medical device manufacturers, meet compliance standards, achieve ongoing TMF Health, and become consistently inspection-ready: what the company refers to as “Reaching the TMF Health Zone.”
Computer Science Graduate of 2015

2019 TMF World Forum Web Header2

 

Each event will feature a series of presentations and panel discussions focused on achieving a balance between people, process, and technology to better achieve TMF Health. The agenda will feature members of the Phlexglobal Expert Services team (some of the leading authorities in TMF management) as well as TMF experts from leading life science companies providing their insight. 

Digital Brain Header Large Brain Right

It's time to raise your standard 

CONTACT PHLEXGLOBAL TODAY
 
Contact Us

Latest News

Overcoming TMF misfiles and metadata errors to reduce inspection risk

Trial master file misfiles are a common occurrence, with as many as one in every 10 documents being misfiled.   In some ways, misfiles are an even greater issue now with eTMF systems, where filing is

TMF Management in Clinical Trials Blog 3: Running the Trial in Your eTMF

Introduction Well, first and foremost, welcome!   Rob Jones has relinquished control and I’ve been given free rein to bring you the last blog in the series on TMF Management in Clinical Trials. Those

TMF Management in Clinical Trials Blog 2: The Path to Metric Nirvana

Good morning, good afternoon, good evening (I like to cover every possibility because who knows when you are reading this)! I hope you all enjoyed part one of this series where we talked about the